Among the bills and holiday cards in more than 1,700 Tarrant County mail boxes is a lumpy, pale blue envelope containing a fecal immunochemical test (FIT) and a chance to participate in a major colon cancer prevention program at JPS.
As Dr. Mark Koch told WFAA health reporter Janet St. James, thousands of the FIT kits will be mailed to JPS Connection patients over the next several years. As well as catching colon cancers in their early, most treatable stage, the program’s goals include identifying the best design for mass screening efforts. The principal investigator is Dr. Keith Argenbright of UT Southwestern/Moncrief Cancer Institute. Drs. Koch and Elizabeth Carter are co-investigators. Stacie Miller is RN team lead on the project, which is funded by the Cancer Prevention and Research Institute of Texas (CPRIT.)
This is the second of two CPRIT projects at JPS. A report on the first was published earlier this year in JAMA Internal Medicine, with Dr. Samir Gupta of the University of California, San Diego as principal investigator.
Comparative Effectiveness of Fecal Immunochemical Test Outreach